ConditionsVirtual RealityDexmedetomidineMaternal AnxietyStressHemodynamicsNeonatal OutcomesCesarean Section
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorBenha University
About this trial
This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.
Eligibility criteria
Qualifiers
Age over 18 years old.
American Society of Anesthesiologists (ASA) physical status II.
Scheduled for elective cesarean section (CS) delivery under Central Neuraxial Blockade.
Provide informed consent and agree to participate in the study.
Disqualifiers
Patient's refusal
Patient known have contraindications for Regional Anesthesia as infection at the site of injection, severe coagulopathy or allergy to local anesthetics.
Patient with psychiatric disorders.
Sensory impairment (blindness, deafness).
Trial design
Treatments tested in this trial
- Dexmedetomidine
- Virtual reality
Treatment groups
52 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov